Jorge Garbino
- Microbiology top 0.1%
-
- Antibiotic Use and Resistance 8
- Infectious Diseases top 0.5%
- Antifungal resistance and susceptibility 31
-
- Nosocomial Infections in ICU 11
- Epidemiology top 0.5%
- Fungal Infections and Studies 22
- Pneumonia and Respiratory Infections 9
- Respiratory viral infections research 7
-
- Infectious Diseases and Mycology 10
-
- Antibiotic Resistance in Bacteria 9
- Co-authors
- Didier PittetPhilippe EggimannDaniel LewJuan AmbrosioniStéphan HarbarthJérôme PuginPeter RohnerLaurent Kaiser
- Journals
- American Journal of Respiratory and Critical Care Medicine (1 paper)Clinical Infectious Diseases (5 papers)CHEST Journal (1 paper)
- Partner nations
- SwitzerlandUnited StatesFrance
In The Last Decade
Jorge Garbino
74 papers receiving 4.7k citations
Hit Papers
Peers
Comparison fields: 5 of 126
- Microbiology 324
- Applied Microbiology and Biotechnology 593
- Infectious Diseases 2.7k
- Critical Care and Intensive Care Medicine 555
- Epidemiology 3.0k
Countries citing papers authored by Jorge Garbino
This map shows the geographic impact of Jorge Garbino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jorge Garbino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jorge Garbino more than expected).
Fields of papers citing papers by Jorge Garbino
This network shows the impact of papers produced by Jorge Garbino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jorge Garbino. The network helps show where Jorge Garbino may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jorge Garbino, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 64 | |
| 2 | 2013 | 97 | |
| 3 | 2010 | 52 | |
| 4 | 2010 | 62 | |
| 5 | 2009 | 27 | |
| 6 | Emerging Zygomycosis Infection: Does Voriconazole Play a Role? | 2008 | 1 |
| 7 | 2008 | 36 | |
| 8 | 2005 | 8 | |
| 9 | 2005 | 35 | |
| 10 | 2004 | 110 | |
| 11 | 2004 | 383 | |
| 12 | 2003 | 2 | |
| 13 | 2003 | 20 | |
| 14 | 2003 | 71 | |
| 15 | 2002 | 110 | |
| 16 | 2001 | 17 | |
| 17 | 2001 | 5 | |
| 18 | 1999 | 22 | |
| 19 | 1999 | 4 | |
| 20 | Cefepime--assessment of its need at a tertiary care center. | 1998 | 3 |
About Jorge Garbino
Jorge Garbino is a scholar working on Microbiology, Applied Microbiology and Biotechnology and Critical Care and Intensive Care Medicine, having authored 75 papers that have together received 4.9k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (31 papers), Fungal Infections and Studies (22 papers), Nosocomial Infections in ICU (11 papers), Infectious Diseases and Mycology (10 papers), Pneumonia and Respiratory Infections (9 papers), Antibiotic Resistance in Bacteria (9 papers), Antibiotic Use and Resistance (8 papers) and Respiratory viral infections research (7 papers). The work is most often cited by research in Microbiology (324 citations), Applied Microbiology and Biotechnology (593 citations) and Infectious Diseases (2.7k citations). Jorge Garbino has collaborated with scholars based in Switzerland, United States and France. Frequent co-authors include Didier Pittet, Philippe Eggimann, Daniel Lew, Juan Ambrosioni, Stéphan Harbarth, Jérôme Pugin, Peter Rohner, Daniel Lew, Laurent Kaiser and Thierry Rochat. Their work appears in journals such as American Journal of Respiratory and Critical Care Medicine, Clinical Infectious Diseases and CHEST Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.